Cargando…
The effects of glucocorticoids and immunosuppressants on cancer outcomes in checkpoint inhibitor therapy
The emergence of checkpoint inhibitors has created a paradigm shift for the treatment of various malignancies. However, although these therapies are associated with improved survival rates, they also carry the risk of immune-related adverse events (irAEs). Moderate to severe irAEs are typically trea...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445222/ https://www.ncbi.nlm.nih.gov/pubmed/36081549 http://dx.doi.org/10.3389/fonc.2022.928390 |